Last update 12 Apr 2025

KRX-211

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
KRX-211
Target
JAK3
Action
inhibitors
Mechanism
JAK3 inhibitors(Tyrosine-protein kinase JAK3 inhibitors)
Therapeutic Areas
Immune System DiseasesInfectious DiseasesOther Diseases
Active Indication-
Inactive Indication
Autoimmune DiseasesGraft RejectionHypersensitivity+ [1]
Originator Organization
Keryx Biopharmaceuticals, Inc.Keryx Biopharmaceuticals, Inc.
Active Organization-
Inactive Organization
Lynx Therapeutics, Inc.Lynx Therapeutics, Inc.Keryx Biopharmaceuticals, Inc.Keryx Biopharmaceuticals, Inc.The Hebrew University of JerusalemThe Hebrew University of Jerusalem
Drug Highest PhasePendingDiscovery
First Approval Date-
Regulation-

Related

100 Clinical Results associated with KRX-211
Login to view more data
100 Translational Medicine associated with KRX-211
Login to view more data
100 Patents (Medical) associated with KRX-211
Login to view more data
100 Deals associated with KRX-211
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Autoimmune DiseasesDiscovery
Israel
The Hebrew University of JerusalemThe Hebrew University of Jerusalem
-
Autoimmune DiseasesDiscovery
Israel
Keryx Biopharmaceuticals, Inc.Keryx Biopharmaceuticals, Inc.
-
Graft RejectionDiscovery
Israel
The Hebrew University of JerusalemThe Hebrew University of Jerusalem
-
Graft RejectionDiscovery
Israel
Keryx Biopharmaceuticals, Inc.Keryx Biopharmaceuticals, Inc.
-
HypersensitivityDiscovery
Israel
The Hebrew University of JerusalemThe Hebrew University of Jerusalem
-
HypersensitivityDiscovery
Israel
Keryx Biopharmaceuticals, Inc.Keryx Biopharmaceuticals, Inc.
-
Shock, SepticDiscovery
United States
Keryx Biopharmaceuticals, Inc.Keryx Biopharmaceuticals, Inc.
-
Shock, SepticDiscovery
Germany
Lynx Therapeutics, Inc.Lynx Therapeutics, Inc.
-
Shock, SepticDiscovery
Israel
The Hebrew University of JerusalemThe Hebrew University of Jerusalem
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free